Pricing Log in Create free account

Incyte Corporation (INCY) vs Roivant Sciences Ltd. (ROIV)

Incyte Corporation and Roivant Sciences Ltd. are both Biotechnology companies. Incyte Corporation and Roivant Sciences Ltd. are of similar size ($26.5B and $24.1B). Roivant Sciences Ltd. has negative trailing earnings, so its P/E is not meaningful; Incyte Corporation trades at 56.8×. Incyte Corporation grew revenue faster over the last twelve months: 24.9% against −67.6%. Incyte Corporation has the higher net margin (6.71% vs −3,535.0%) and the higher return on invested capital (21.6% vs −34.5%). Across the 18 metrics below, Incyte Corporation leads on 16 and Roivant Sciences Ltd. on 2.

Valuation

Metric INCY ROIV Biotechnology median
P/E 56.81 n/m 10.60
P/S 4.03 3,722.55 9.40
P/B 4.29 5.70 2.13
Price to free cash flow 35.64 n/m 25.18
EV/EBITDA 28.16 n/m 0.66
EV/Sales 3.40 3,255.42 9.02
Earnings yield 1.76% (0.98%) (32.88%)
Free cash flow yield 2.81% (2.93%) (23.13%)

Profitability

Metric INCY ROIV Biotechnology median
Gross margin 92.69% 81.21% 68.51%
Operating margin 10.42% (7,914.75%) 0.00%
Net margin 6.71% (3,534.96%) 0.00%
Free cash flow margin 11.31% (10,901.00%) 0.00%
Return on equity 7.84% (5.47%) (51.96%)
Return on assets 5.92% (5.15%) (46.06%)
Return on invested capital 21.56% (34.51%) 0.00%

Growth

Metric INCY ROIV Biotechnology median
Revenue growth (TTM) 24.88% (67.58%) 6.76%
EPS growth (last fiscal year) 4,173.33% (125.00%) 29.88%
Revenue growth, 5-year CAGR 14.03% (19.07%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INCY ROIV Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.84 16.72 4.97
Net debt to EBITDA (2.21) 8.39 1.01

Dividend

Metric INCY ROIV Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric INCY ROIV Biotechnology median
Market cap 24.05b 26.45b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack